A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1999
12/16/1999	WO1999064029A1 Plant extract
12/16/1999	WO1999064021A1 hCEPR RECEPTOR
12/16/1999	WO1999064020A1 Use of ozone for the preparation of medicaments for the treatment of dental caries
12/16/1999	WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999	WO1999064001A2 Methods and compositions for increasing penetration of hiv protease inhibitors
12/16/1999	WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063975A2 A method for stimulating the immune system
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063934A2 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999	WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	WO1999063816A1 Method and composition for the treatment of epidermal irritations and infections
12/16/1999	WO1999057292A9 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
12/16/1999	WO1999055348A3 Stabilised virus preparation
12/16/1999	WO1999049017A3 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
12/16/1999	WO1999048461A3 Substituted aromatic compounds for treatment of antibiotic resistant infections
12/16/1999	WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999	CA2706350A1 Method of hiv and hpv prophylaxis
12/16/1999	CA2335339A1 .beta.-carboline compounds
12/16/1999	CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999	CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999	CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999	CA2334760A1 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999	CA2334431A1 Use of ozone for the preparation of medicaments for the treatment of dental caries
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999	CA2333550A1 Crystalline efavirenz
12/16/1999	CA2333332A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999	CA2332831A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999	CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	CA2330238A1 Vaccine
12/16/1999	CA2330230A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/15/1999	EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection
12/15/1999	EP0963431A1 NOVEL FabH
12/15/1999	EP0963371A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation
12/15/1999	EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999	EP0749434B1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/15/1999	EP0658110B1 Use of norastemizole for the treatment of allergic rhinitis
12/15/1999	EP0643585B1 The use of Lipoprotein Associated Coagulation Inhibitor (LACI) for the preparation of a medicament for the treatment of acute or chronic inflammation.
12/15/1999	EP0623167B1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
12/15/1999	EP0529008B1 Modulation of gene expression through interference with rna secondary structure
12/15/1999	CN1238783A Method and novel compounds for use therein
12/15/1999	CN1238782A Colostrinin and uses thereof
12/15/1999	CN1238776A Process for the preparation of salts and esters of clavulanic acid
12/15/1999	CN1238775A Cephalosporin derivatives
12/15/1999	CN1238762A Piperidine compounds
12/15/1999	CN1238696A Vaccines
12/15/1999	CN1238695A Topical composition for preventing or treating bacterial skin infections
12/15/1999	CN1238687A An oil composition of dihydropolyprenols
12/15/1999	CN1047307C Application of aucubine for the treatment of hepatitis B virus (HBV) infection
12/14/1999	US6001998 Macrocyclic lactone compounds and their production process
12/14/1999	US6001989 Nucleotide based endonucleases
12/14/1999	US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999	US6001973 Antagonists of interleukin-15
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001961 Cyclic adhesion inhibitors
12/14/1999	US6001880 Disubstituted n-(2-dialkylaminoethyl)benzamide derivatives of given formula; antibacterial activity against helicobacter pyroli, administering for the prevention or cure of peptic ulcers
12/14/1999	US6001870 Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/14/1999	US6001819 Bacterial inhibition with an oligosaccharide compound
12/14/1999	US6001810 Methods for treating retroviral infection
12/14/1999	US6001808 Administering effective amount of gramicidin for therapy and prevention
12/14/1999	US6001806 Aministering to patients in need of elevated levels of interferon, drugs selected from polypepides of specified amino acid sequences and a carrier
12/14/1999	US6001799 Method of treating hepatitis C in non-responders to interferon treatment
12/14/1999	US6001651 Antisense modulation of LFA-3
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999	US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999	US6001372 Can be used to stimulate antigenic responses and to diagnose the presence of the bacteria
12/14/1999	US6001371 Relates to recombinant baculoviruses encoding parvovirus structural proteins and host cells infected therewith; method of packaging and delivering genetic information utilizing the noninfectious capsids
12/14/1999	US6001370 New attenuated strain allows the obtaining of vaccines and diagnostic kits which make possible both the early diagnosis of porcine reproductive respiratory syndrome and an efficient preventive treatment of such disease
12/14/1999	US6001365 Conjugating empty human class i molecules surface-expressed on drosophila cells to a toxin in vitro; contacting said molecules with antigenic peptides derived from said transplanted tissue to load said conjugates with peptides
12/14/1999	US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999	US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2138873C Composition against acne insuring the simultaneous treatment of the superficial and deep layers of the skin, and its use
12/14/1999	CA2135642C Tat-derived transport polypeptides
12/14/1999	CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999	CA2074503C Pharmaceutical formulation containing penciclovir
12/14/1999	CA2014555C Preventive and curative medicament against infection with influeza virus
12/14/1999	CA2010636C Substituted pyrroles
12/14/1999	CA1340848C Pseudorabies virus protein
12/14/1999	CA1340847C Adhesin antigens

1 ... 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 ... 1798